- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this study, over the next five years the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market will register a 22.2%% CAGR in terms of revenue, the global market size will reach $ 20990 million by 2025, from $ 9412.1 million in 2019. In particular, this report presents the global revenue market share of key companies in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), covering the supply chain analysis, impact assessment to the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size growth rate in several scenarios, and the measures to be undertaken by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
CellSearch
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Janssen
Gilupi
Qiagen
ApoCell
Biofluidica
Advanced Cell Diagnostics
Celsee
Clearbridge Biomedics
Fluxion
CytoTrack
Ikonisys
IVDiagnostics
AdnaGen
Cynvenio
BioView
YZY Bio
ScreenCell
Fluidigm
On-chip
Miltenyi Biotec
Silicon Biosystems
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by identifying its various subsegments.
Focuses on the key global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2015-2025
2.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Region
2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Type
2.2.1 CellSearch
2.2.2 CellSearch
2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
2.3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2015-2020)
2.3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type (2015-2020)
2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Application
2.4.1 Breast Cancer Diagnosis and Treatment
2.4.2 Prostate Cancer Diagnosis and Treatment
2.4.3 Colorectal Cancer Diagnosis and Treatment
2.4.4 Lung Cancer Diagnosis and Treatment
2.4.5 Other Cancers Diagnosis and Treatment
2.5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
2.5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2015-2020)
2.5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Application (2015-2020)
3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Players
3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Players (2018-2020)
3.1.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Players (2018-2020)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions
4.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions
4.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
4.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
4.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
4.5 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
5 Americas
5.1 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries
5.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
5.3 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions
6.2 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
6.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries
7.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
7.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries
8.2 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
8.3 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast (2021-2025)
10.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions
10.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Type
10.8 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Application
11 Key Players Analysis
11.1 Janssen
11.1.1 Company Details
11.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Janssen News
11.2 Gilupi
11.2.1 Company Details
11.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.2.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Gilupi News
11.3 Qiagen
11.3.1 Company Details
11.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.3.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Qiagen News
11.4 ApoCell
11.4.1 Company Details
11.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 ApoCell News
11.5 Biofluidica
11.5.1 Company Details
11.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Biofluidica News
11.6 Advanced Cell Diagnostics
11.6.1 Company Details
11.6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.6.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Advanced Cell Diagnostics News
11.7 Celsee
11.7.1 Company Details
11.7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.7.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Celsee News
11.8 Clearbridge Biomedics
11.8.1 Company Details
11.8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.8.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Clearbridge Biomedics News
11.9 Fluxion
11.9.1 Company Details
11.9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Fluxion News
11.10 CytoTrack
11.10.1 Company Details
11.10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.10.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 CytoTrack News
11.11 Ikonisys
11.12 IVDiagnostics
11.13 AdnaGen
11.14 Cynvenio
11.15 BioView
11.16 YZY Bio
11.17 ScreenCell
11.18 Fluidigm
11.19 On-chip
11.20 Miltenyi Biotec
11.21 Silicon Biosystems
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of CellSearch
Table 5. Major Players of Others
Table 6. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2015-2020)
Table 8. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2015-2020)
Table 10. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Players (2018-2020)
Table 12. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Products Offered
Table 13. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Regions 2015-2020
Table 18. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries (2015-2020)
Table 20. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2015-2020)
Table 22. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2015-2020)
Table 24. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Regions (2015-2020)
Table 26. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2015-2020)
Table 28. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2015-2020)
Table 30. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries (2015-2020)
Table 32. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2015-2020)
Table 34. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 43. Key Application and Potential Industries of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 44. Key Challenges of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 45. Key Trends of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 46. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Regions
Table 48. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Application (2021-2025)
Table 52. Janssen Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 53. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 54. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 55. Janssen Main Business
Table 56. Janssen Latest Developments
Table 57. Gilupi Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 58. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 59. Gilupi Main Business
Table 60. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 61. Gilupi Latest Developments
Table 62. Qiagen Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 63. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 64. Qiagen Main Business
Table 65. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 66. Qiagen Latest Developments
Table 67. ApoCell Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 68. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 69. ApoCell Main Business
Table 70. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 71. ApoCell Latest Developments
Table 72. Biofluidica Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 73. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 74. Biofluidica Main Business
Table 75. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 76. Biofluidica Latest Developments
Table 77. Advanced Cell Diagnostics Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 78. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 79. Advanced Cell Diagnostics Main Business
Table 80. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 81. Advanced Cell Diagnostics Latest Developments
Table 82. Celsee Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 83. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 84. Celsee Main Business
Table 85. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 86. Celsee Latest Developments
Table 87. Clearbridge Biomedics Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 88. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 89. Clearbridge Biomedics Main Business
Table 90. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 91. Clearbridge Biomedics Latest Developments
Table 92. Fluxion Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 93. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 94. Fluxion Main Business
Table 95. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 96. Fluxion Latest Developments
Table 97. CytoTrack Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 98. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 99. CytoTrack Main Business
Table 100. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (2018-2020E)
Table 101. CytoTrack Latest Developments
Table 102. Ikonisys Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 103. IVDiagnostics Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 104. AdnaGen Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 105. Cynvenio Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 106. BioView Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 107. YZY Bio Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 108. ScreenCell Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 109. Fluidigm Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 110. On-chip Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 111. Miltenyi Biotec Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
Table 112. Silicon Biosystems Details, Company Total Revenue (in $ million), Head Office, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Market Areas and Its Competitors
List of Figures
Figure 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2015-2020)
Figure 5. Global CellSearch Market Size Growth Rate
Figure 6. Global Others Market Size Growth Rate
Figure 7. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Breast Cancer Diagnosis and Treatment
Figure 8. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Breast Cancer Diagnosis and Treatment (2015-2020) ($ Millions)
Figure 9. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Prostate Cancer Diagnosis and Treatment
Figure 10. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Prostate Cancer Diagnosis and Treatment (2015-2020) ($ Millions)
Figure 11. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Colorectal Cancer Diagnosis and Treatment
Figure 12. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Colorectal Cancer Diagnosis and Treatment (2015-2020) ($ Millions)
Figure 13. Global Colorectal Cancer Diagnosis and Treatment YoY Growth ($ Millions)
Figure 14. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Lung Cancer Diagnosis and Treatment
Figure 15. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Lung Cancer Diagnosis and Treatment (2015-2020) ($ Millions)
Figure 16. Global Lung Cancer Diagnosis and Treatment YoY Growth ($ Millions)
Figure 17. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Other Cancers Diagnosis and Treatment
Figure 18. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Other Cancers Diagnosis and Treatment (2015-2020) ($ Millions)
Figure 19. Global Other Cancers Diagnosis and Treatment YoY Growth ($ Millions)
Figure 20. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2019
Figure 21. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Regions 2015-2020
Figure 22. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2015-2020 ($ Millions)
Figure 23. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2015-2020 ($ Millions)
Figure 24. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2015-2020 ($ Millions)
Figure 26. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries in 2019
Figure 27. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2019
Figure 28. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2019
Figure 29. United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Regions in 2019
Figure 33. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2019
Figure 34. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2019
Figure 35. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries in 2019
Figure 42. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2019
Figure 43. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2019
Figure 44. Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application in 2019
Figure 53. Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 60. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 61. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 63. United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 64. Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 67. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 68. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 69. Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 71. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 72. Australia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 73. Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 74. France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 75. UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 76. Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 77. Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 78. Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 81. Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2021-2025 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
